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The suppressor of cytokine signaling/cytokine-induci-
ble SH2 containing proteins are cytokine inducible and
are negative regulators of the signal transducers and
activators of the transcription signaling pathway. We
investigated the mechanism regulating signal transducers
and activators of transcription and the suppressor of cy-
tokine signaling/cytokine-inducible SH2 containing
protein family in keratinocytes, one of the major target
cells for cytokines. Suppressor of cytokine signaling
1 mRNA was upregulated 3 h post-interferon c, and a
8.1-fold increase in the suppressor of cytokine signaling
1 mRNA occurred 48 h post-interferon c. The suppres-
sor of cytokine signaling 3 mRNAwas also upregulated
from 1 h post-interferon c, and a 6.7-fold increase in the
suppressor of cytokine signaling 3/cytokine-inducible
SH2 containing protein 3 mRNA occurred between
6 and 12 h post-interferon c. Interleukin-6 exposure for
1 h enhanced the expression of the suppressor of cytokine
signaling 3/cytokine-inducible SH2 containing protein
3 mRNA, but the suppressor of cytokine signaling
1/JAB mRNAwas not induced by interleukin-6. Inter-
leukin-4 upregulated the suppressor of cytokine signaling
1/JAB and cytokine-inducible SH2 containing protein 1
mRNA, with 3.4-fold and 5.1-fold increases in mRNA
observed at 1 h post-interleukin-4, respectively. In con-
trast, epidermal growth factor, which phosphorylates
signal transducers and activators of transcription 3, did
not in£uence the level of the suppressor of cytokine
signaling/cytokine-inducible SH2 containing protein
family mRNA expression. Transfection of an adenovirus
vector expressing the suppressor of cytokine signaling
1/JAB completely inhibited interferon c-dependent
signal transducers and activators of transcription 1
phosphorylation and interleukin-4-dependent signal
transducers and activators of transcription 6 phosphory-
lation. Transfection of adenovirus vector expressing the
suppressor of cytokine signaling 1/JAB did not inhibit
interleukin-6-dependent signal transducers and activa-
tors of transcription 3 phosphorylation4several reports
show that the suppressor of cytokine signaling 1/JAB is
a potent inhibitor of signal transducers and activators of
transcription 3 signaling in the myeloid leukemia M1
cell. Transfection of the adenovirus vector expressing
suppressor of cytokine signaling 3/cytokine-inducible
SH2 containing protein 3 completely inhibited interleu-
kin-6-dependent signal transducers and activators of
transcription 3 phosphorylation and partially inhibited
interferon c-dependent signal transducers and activators
of transcription 1 phosphorylation. Transfection of the
adenovirus vector expressing suppressor of cytokine sig-
naling 3/cytokine-inducible SH2 containing protein 3,
however, did not inhibit interleukin-4-dependent
signal transducers and activators of transcription
6 phosphorylation. Transfection of the adenovirus vec-
tor expressing cytokine-inducible SH2 containing pro-
tein 1 had no e¡ect on signal transducers and activators
of transcription 1, 3, and 6 signaling in normal keratino-
cytes. Therefore, the relationship between signal trans-
ducers and activators of transcription and suppressor of
cytokine signaling is unique in the keratinocytes, and
the suppressor of cytokine signaling regulates cytokine
signals in these cells. Key words: Keratinocyte/SOCS/CIS/
STAT/interferon gamma/Interleukin-4/Interleukin-6. J Invest
Dermatol 120:571 ^580, 2003
T
heskin is composed of the epidermis and the dermis,
and keratinocytes are the major cells of the epider-
mis. Many di¡erent cytokines in£uence the dy-
namics of keratinocyte function, including interferon
(IFN)-g, interleukin (IL)-4, and IL-6 (Furue, 1994;
Ricci, 1994; Fransson et al, 1996; Huang et al, 2001). IFN-g is
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secreted fromT helper (Th)1 lymphocytes, and is a possible psor-
iasis pathogen (Schlaak et al, 1994). IFN-g induces the expression
of molecules that recruit and activate T cells and other leukocytes
in the skin (Barker et al, 1990). Th2-derived IL-4 is abundantly
expressed in atopic dermatitis (Del Prete, 1992; Furue, 1994; Ricci,
1994). The balance between Th1 and Th2 cells a¡ects both kerati-
nocyte growth and the expression of chemoattractants by kerati-
nocytes (Fransson et al, 1996;Vestergaard et al, 2000). Many aspects
of the biologic functions of these cytokines have been investi-
gated, but their role in regulating intracellular signal transduction
in human keratinocytes is not fully understood. Recent studies
indicate that signal transducers and activators of transcription
(STAT), and their negative regulators, the suppressor of cytokine
signaling (SOCS)/cytokine-inducible SH2 containing protein
(CIS) family of proteins, play a central role in this regulatory me-
chanism in various di¡erent cell types.
STATare crucial molecules for the cytokine-signaling pathway.
STAT transmit cytokine-derived signals to the nucleus of the cell
(Bromberg and Darnell, 2000). Seven isotypes of STATmolecules
have been identi¢ed: STAT1, STAT2, STAT3, STAT4, STAT5a,
STAT5b, and STAT6. STAT1 and STAT2 transduce signals from
IFN-a, b, and g. STAT3 transduces gp130 receptor signaling,
which is activated by IL-6 and IL-10. Epidermal growth factor
(EGF) and platelet-derived growth factor also phosphorylate
STAT3. STAT4 is an important molecule in the IL-12 signaling
pathway, and STAT5a and STAT5b are stimulated by IL-2 and
erythropoietin. STAT6 is important for IL-4 and IL-13 signaling.
After a cytokine binds to its receptor, Janus-activated kinase
(JAK) is phosphorylated (Imada and Leonard, 2000; Kotenko
and Pestka, 2000; Gadina et al, 2001). Then, JAK, in turn, phos-
phorylates the cytokine receptor. STAT binds to the phosphory-
lated receptor, and STAT is subsequently phosphorylated by JAK.
The phosphorylated STATmolecule then forms a homodimer or
heterodimer, and translocates into the nucleus, where it initiates
the transcription of a candidate gene.
Recently, the SOCS/CIS family and the protein inhibitor of
activated STATwere isolated as negative regulators or modulators
of the cytokine/STAT signaling pathway(Duhe et al, 2001). The
protein inhibitor of activated STAT is found constitutively in the
cytoplasm and regulates the translocation of phosphorylated
STAT to the nucleus by binding to phosphorylated STAT (Liu
et al, 1998). The SOCS/CIS family is inducible de novo by cytokine
stimulation. Synthesized SOCS/CIS protein binds to tyrosine
phosphorylated sites of the cytokine receptor or JAK through
an SH2 domain, and consequently inhibits phosphorylation of
tyrosine kinase. Yoshimura et al (1995) ¢rst isolated CIS as an
erythropoietin signal inhibitor that binds to the tyrosine-phos-
phorylated site of the erythropoietin receptor and inhibits the
downstream signal of STAT5 activation. New members of the
SOCS/CIS family have been identi¢ed independently (Endo
et al, 1997; Naka et al, 1997; Starr et al, 1997). SOCS1/JAB mainly
binds to JAK2 (Yasukawa et al, 1999) and works as a crucial
molecule regulating IFN-g/STAT1 (Alexander et al, 1999) and
IL-6/STAT3 signaling in some cell types (Naka et al, 1997).
SOCS2/CIS2 is predicted to be a critical regulator of insulin-like
growth factor and the insulin-like growth factor receptor signal
(Metcalf et al, 2000) based on evidence from the SOCS2/CIS2
knockout mouse, which showed gigantism as an abnormal phe-
notype. SOCS3/CIS3 is reported to regulate the IL-6/STAT3 and
IFN-g/STAT1 signaling pathways. The functions of the other
members of the SOCS/CIS family, SOCS4^SOCS7, remain
unclear.
The relationship between cytokines and the SOCS/CIS family
and the inhibitory pro¢le of the SOCS/CIS family di¡er among
cell types. The inhibitory and negative regulatory mechanisms of
cytokine signals in epidermal keratinocytes have not been fully
assessed, although cytokines such as IFN-g, IL-4, and IL-6 are
implicated in a variety of physiologic and pathologic conditions
of the skin.
We studied SOCS/CIS function in normal human epidermal
keratinocytes using an adenovirus expression system. The results
suggest that SOCS is one of the major negative regulators of the
cytokine/STAT signaling pathway in human keratinocytes.
MATERIALS ANDMETHODS
Cell culture Normal human skin was obtained from plastic surgery
patients, cut into 3^5 mm strips, and incubated with 250 U per ml of
dispase in Dulbecco’s modi¢ed Eagle’s medium overnight at 41C. The
epidermis was separated from the dermis with forceps, and the epidermal
sheets were rinsed with phosphate-bu¡ered saline, incubated in a 0.25%
trypsin solution for 10 min at 371C, and then teased with forceps.
Epidermal cells were rinsed and collected by centrifugation. Normal
human keratinocytes were cultured in MCDB153 medium supplemented
with insulin (5 mg per ml), hydrocortisone (5107 M), ethanolamine
(0.1 mM), phosphoethanolamine (0.1 mM), bovine hypothalamic extract
(50 mg per ml), and Ca2þ (0.03 mM). This supplement has been described
elsewhere (Sayama et al, 1999). Cells were counted using a Coultert Z1
Cell Counter (Coulter, Tokyo, Japan). All procedures involving human
subjects received prior approval from the ethical committee of Ehime
University School of Medicine, and all subjects provided informed
written consent.
Reagents Recombinant IFN-g and EGF were generous gifts from
Otsuka Pharmaceutical Co. Ltd. (Tokyo, Japan). Recombinant IL-6 and
IL-4 were obtained from PeproTech EC Ltd. (London, U.K.).
Anti-phosphoSTAT1 (a-pSTAT1), anti-phosphoSTAT3 (a-pSTAT3), and
anti-phosphoSTAT6 (a-pSTAT6) antibodies were purchased from New
England Biolabs (Beverly, MA). Anti-STAT1 (a-STAT1) and anti-STAT3
(a-STAT3) antibodies were purchased from Promega (Tokyo, Japan).
Anti-STAT6 (a-STAT6) antibody was purchased from Transduction
Laboratories (Lexington, KY).
Oligonucleotide probe preparation Polymerase chain reaction
ampli¢ed human cDNAwere inserted into the EcoRI and HindIII sites of
the pPMG vector (PharMingen, San Diego). Inserted cDNA corresponded
to oligonucleotides 550^769 of STAT1 (accession no. M97935), 345^586
of STAT2 (accession no. M97934), 1846^2109 of STAT3 (accession
no. L29277), 1824^2109 of STAT4 (accession no. L78440), 1773^2085 of
STAT5a (accession no. U43185), 2115^2448 of STAT5b (accession
no. U47686), 1500^1854 of STAT6 (accession no. U16031), 395^554 of
CIS1 (accession no. AF132297), 351^525 of SOCS1/JAB (accession
no. AB005043), 83^273 of SOCS2/CIS2 (accession no. AB004903), and
556^764 of SOCS3/CIS3 (accession no. AB004904). These inserted cDNA
were con¢rmed by nucleotide sequencing. The pPMG vector, including
GAPDH cDNA (PharMingen), was used as the internal standard.
Ribonuclease protection assay Keratinocytes derived from three
independent donors were used for ribonuclease protection assays. Total
cellular RNA was isolated from cultured human keratinocytes using
Isogens (Nippon Gene,Toyama, Japan).
Single-stranded anti-sense riboprobes were prepared by in vitro
transcription of human cDNA fragments, using a RiboQuants In Vitro
Transcription kit (PharMingen) in the presence of [a-32P]uridine
triphosphate. Samples of total RNA (10 mg each) were hybridized with
32P-labeled riboprobe and digested with RNase using the RiboQuants
ribonuclease protection assay kit according to the manufacturer’s
instructions. Hybridization products were separated on a 5% poly-
acrylamide/8 M urea gel. The gel was absorbed on ¢lter paper, dried, and
then exposed to Kodak BiomaxMSs ¢lm (Kodak, Japan) at701C. Band
density was analyzed using the Diversity Databaset (PDI Inc., NewYork).
Relative values of SOCS/CIS mRNAwere estimated using GAPDH as an
internal reference, and normalized against the respective relative value at
0 h poststimulation. Reproducibility was con¢rmed by performing three
independent experiments using keratinocytes derived from three
independent donors. Typical results were represented as photo images. The
mean and standard deviation of relative values obtained from three
independent experiments using keratinocytes derived from three
independent donors were plotted on graphs.
Adenovirus vector construction and infection The cosmid cassettes
pAxCAw (Miyake et al, 1996) and pAxCALNLw (Kanegae et al, 1996),
nuclear localizing signal-tagged Cre recombinase-expressing adenovirus
(AxCANCre), control adenovirus Ax1w, and the parent virus Ad5-dLX
(Miyake et al, 1996) were all kind gifts from Dr Izumu Saito (Tokyo
University, Japan). The full-length coding regions of STAT1W, STAT1F,
STAT3W, STAT3F, and SOCS3/CIS3 cDNA were subcloned into the
adenovirus cosmid cassette pAxCAw. STAT1W, and STAT3W code
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normal STAT1 and STAT3 sequences, respectively. STAT1F and
STAT3F code dominant negative mutants that have their tyrosine
phosphorylation sites changed to phenylalanine. The full-length coding
regions of CIS1 and SOCS1/JAB cDNA were subcloned into
pAxCALNLw. Adenovirus containing the CA promoter and STAT1W,
STAT1F, STAT3W, STAT3F, or CIS3 (AxCAStat1w, AxCAStat1F,
AxCAStat3w, AxCAStat3F, and AxCACIS3, respectively), and adenovirus
containing the CALNL unit and CIS1 or JAB (AxCALNLCIS1 and
AxCALNLJAB, respectively) were generated using the COS-TPC
method (Miyake et al, 1996). The cosmid DNA was mixed with the
EcoT22I-digested DNA-terminal Ad5-dLX protein complex, and used to
cotransfect 293 cells. Recombinant viruses were generated through
homologous recombination in 293 cells. Virus stocks were prepared using
a standard procedure (Miyake et al, 1996). Concentrated, puri¢ed virus
stocks were prepared by a CsCl gradient, and the virus titer was checked
by plaque formation assay.
Normal human keratinocytes were infected with adenovirus vectors at a
multiplicity of infection of 5. AxCALNLJAB and AxCALNLCIS1 were
transfected with AxCANCre, because they can generate SOCS1/JAB and
CIS1 mRNA under the in£uence of Cre recombinase. The expression of
these genes was con¢rmed with reverse transcription^polymerase chain
reaction using the speci¢c probes described above.
Western blot analysis Cells were harvested by scraping with extraction
bu¡er, containing 150 mM NaCl, 1% nonidet P-40, 0.5% deoxycholate,
0.1% sodium dodecyl sulfate, 50 mM Tris^HCl pH 7.4, and pro-
tease inhibitors. Equal amounts of protein were separated by sodium
dodecyl sulfate^polyacrylamide gel electrophoresis, and transferred to
polyvinylidene di£uoride membranes. The ¢rst antibodies were incubated
overnight at 41C. Fluorescein-labeled goat anti-mouse or rabbit IgG
(Amersham Life Science, Inc., Arlington Heights, IL) were used as the
second antibody. The signal was ampli¢ed with an anti-£uorescein
antibody followed by a £uorescent substrate, AttoPhos (Amersham Life
Science, Inc.). The membrane was then scanned using FluoroImager
(Molecular Dynamics Inc., Sunnyvale, CA). The intensity of each band
was quanti¢ed with ImageQuantt (Molecular Dynamics Inc.), with
reference to the control signal as one unit. Reproducibility was con¢rmed
by performing three independent experiments using keratinocytes derived
from three independent donors.
RESULTS
Upregulation of SOCS1/JAB and SOCS3/CIS3 mRNA by
IFN-c We ¢rst examined the e¡ect of IFN-g on STAT and
SOCS/CIS expressions in primary keratinocytes. IFN-g is a potent
anti-proliferating agent of primary keratinocytes (Nickolo¡ et al,
1984), and phosphorylates STAT1 and STAT2 (Bromberg and
Darnell, 2000). Following the application of IFN-g, cells were
harvested at the indicated time and total RNA was analyzed
by a ribonuclease protection assay (Fig 1a). In quiescent
keratinocytes, STAT1, STAT2, STAT3, STAT5b, and STAT6
were dominantly expressed. IFN-g enhanced STAT1 and STAT2
mRNA expression in a time-dependent manner. IFN-g
had no e¡ect on the expression of STAT3, STAT5b, or STAT6
mRNA. Quiescent keratinocytes did not express STAT4 or
STAT5a mRNA, but STAT5a mRNA was induced 12^48 h
post-IFN-g, and STAT4 was induced 24^48 h post-IFN-g.
Along with the induction of STAT1 and STAT2 mRNA,
SOCS1/JAB and SOCS3/CIS3 mRNA were expressed in a
time-dependent manner. SOCS3/CIS3 mRNA was rapidly
upregulated 1 h post-IFN-g, and was increased 6.7-fold at 6^12 h
post-IFN-g (Fig 1b). SOCS1/JAB mRNA was detectable 3 h
post-IFN-g and increased 8.1-fold after 48 h of IFN-g exposure
(Fig 1c). SOCS2/CIS2 mRNA was downregulated by IFN-g
(Fig 1d), and CIS1 levels were induced 3^4-fold 1^48 h post-IFN-
g (Fig 1e).
Upregulation of SOCS3/CIS3 mRNA but not SOCS1/JAB
mRNA by IL-6 IL-6 phosphorylates STAT3 in keratinocytes
(Sano et al, 1999; Hirano et al, 2000). In contrast to IFN-g, IL-6
did not alter the expression of STAT family mRNA in
keratinocytes (Fig 2a); however, IL-6 strongly enhanced the
expression of SOCS3/CIS3 mRNA, with a 8.7-fold increase at
1 h post-IL-6 (Fig 2b). Furthermore, SOCS3/CIS3 expression was
slightly decreased at 3 h, and then increased 2^3-fold from 6 to
48 h. SOCS1/JAB mRNA is not induced by IL-6 stimulation in
keratinocytes (Fig 2c). The expression of CIS1 and SOCS2/CIS2
mRNAwere not a¡ected by IL-6 (Fig 2d,e, respectively).
Upregulation of SOCS1/JAB and CIS1 mRNA by IL-4 IL-
4 is produced byTh2 cells in atopic skin conditions (Ricci, 1994),
and the IL-4 signal is transduced by STAT6 (Takeda et al, 1996,
1997). IL-4 stimulation did not alter the expression of STAT
family mRNA in keratinocytes, as did IL-6 stimulation (Fig
3a). A 3.5-fold increase in SOCS1/JAB mRNAwas induced 1 h
post-IL-4 in keratinocytes (Fig 3c). IL-4-dependent SOCS1/JAB
induction seemed to be biphasic, with peaks at 1^3 h and 12^36 h.
A 4.8-fold increase in CIS1mRNAwas also induced 1 h post-IL-
4 (Fig 3e). IL-4-dependent CIS1 induction was also biphasic,
with peaks at 1^3 h and 24^48 h. IL-4 had no e¡ect on SOCS2/
CIS2 and SOCS3/CIS3 (Fig 3b,d, respectively).
E¡ect of EGF on SOCS/CIS family mRNA EGF is a potent
mitogen for keratinocytes, and it was reported that EGF
phosphorylates the STAT3 and MAP kinase family (Olayioye et
al, 1999). EGF induced a transient increase in STAT1, STAT2, and
STAT3 mRNA 1 h after keratinocyte stimulation (Fig 4a). After
a 1 h stimulation, EGF also induced a slight increase in SOCS1/JAB
mRNA (Fig 4c), and downregulated SOCS3/CIS3 mRNA. In
contrast, IFN-g and IL-6 upregulated SOCS3/CIS3 mRNA
(Fig 4b). EGF did not alter the expression of CIS1 and SOCS2/
CIS2 mRNA (Fig 4d and 4e, respectively).
E¡ect of SOCS1/JAB on IFN-c-induced STAT1 phospho-
rylation We demonstrated that cytokines such as IFN-g,
IL-6, and IL-4 induce their negative regulators, CIS1, SOCS1/
JAB, and SOCS3/CIS3, in keratinocytes; however, it has not
been proven whether this SOCS family of proteins is able to
inhibit the cytokine-signaling pathway. To study the functional
role of SOCS/CIS proteins that are expressed in keratinocytes,
we used an adenovirus vector expressing normal CIS1
(AxCALNLCIS1), normal SOCS1/JAB (AxCALNLJAB), and
normal SOCS3/CIS3 (AxCACIS3).
STAT1 is phosphorylated by IFN-g.We examined the e¡ect of
CIS1, SOCS1/JAB, and SOCS3/CIS3 on IFN-g-induced STAT1
phosphorylation levels in keratinocytes. The adenovirus vectors
were added to medium containing keratinocytes and incubated
for 24 h to induce SOCS/CIS protein production. Then,
keratinocytes were stimulated with IFN-g. The proteins
extracted from keratinocytes (treated or untreated with IFN-g)
were analyzed by western blot analysis.
AxCALNLJAB completely inhibited IFN-g-induced STAT1
phosphorylation in keratinocytes, whereas AxCACIS3 weakly
reduced the STAT1 phosphorylation level (Fig 5a). AxCIS1 had
no e¡ect on IFN-g-induced STAT1 phosphorylation. Time-
course studies of AxCALNLJAB- and AxCACIS3-transfected
keratinocytes con¢rmed that IFN-g-induced STAT1 phosph-
orylation was inhibited by SOCS1/JAB (Fig 5b,c). These
data indicate strong inhibition of IFN-g-induced STAT1
phosphorylation by SOCS1/JAB, and weak inhibition by
SOCS3/CIS3.
Inhibition of IL-6-induced STAT3 phosphorylation by
SOCS3/CIS3 We examined the e¡ect of CIS1, SOCS1/JAB, and
SOCS3/CIS3 on IL-6-induced STAT3 phosphorylation using
an adenovirus vector system as described above. AxCACIS3
completely inhibited IL-6-induced STAT3 phosphorylation in
keratinocytes (Fig 6a). This observation is consistent with
previous reports involving myeloid leukemia M1 cells (Endo
et al, 1997; Naka et al, 1997; Starr et al, 1997). Interestingly,
AxCALNLJAB did not a¡ect IL-6-dependent STAT3
phosphorylation in keratinocytes. This result does not agree with
M1 cell observations; in these cells SOCS1/JAB works as a potent
inhibitor of the IL-6-induced STAT3 signaling pathway (Endo
et al, 1997; Naka et al, 1997; Starr et al, 1997). Time-course studies of
NEGATIVE REGULATION OF STAT SIGNALING BY SOCS FAMILY IN KERATINOCYTES 573VOL. 120, NO. 4 APRIL 2003
AxCALNLJAB- and AxCACIS3-transfected keratinocytes
con¢rmed that IL-6-induced STAT3 phosphorylation was not
inhibited by SOCS1/JAB (Fig 6b,c). CIS1 had no e¡ect on IL-6-
induced STAT3 phosphorylation. As IL-6 induced SOCS3/CIS3
mRNA expression only in keratinocytes (as shown in Fig 2a),
SOCS3/CIS3 may be a major negative regulator in the
keratinocyte IL-6-induced STAT3 signaling pathway.
Inhibition of IL-4-induced STAT6 phosphorylation by
SOCS1/JAB STAT6 is an essential signal transducer of IL-4
stimulation. The inhibitory e¡ect of SOCS/CIS proteins on IL-
4-induced STAT6 phosphorylation was studied. IL-4 enhanced
the expression of SOCS1/JAB and CIS1 mRNA (Fig 3a).
AxCALNLJAB inhibited IL-4-dependent STAT6 phosphorylation
(Fig 7a,b); however, CIS1 did not a¡ect IL-4-induced STAT6
phosphorylation, although CIS1 is upregulated by IL-4
stimulation (Fig 7a,c). Although a previous study shows
SOCS3/CSI3 inhibit IL-4-dependent STAT6 activation (Haque
et al, 2000), SOCS3/CIS3 had no e¡ect on IL-4-induced STAT6
phosphorylation in human keratinocytes. Hence, the SOCS1/JAB
protein is a major negative regulator of IL-4-induced STAT6
activation.
Figure1. Induction of SOCS/CIS mRNA by IFN-c in keratinocytes. IFN-g (10 IU per ml) was added to keratinocytes in culture medium, and total
RNAwas extracted at 0, 1, 3, 6, 12, 24, 36, and 48 h after stimulation. Total RNAwas hybridized with RNA probes, and separated on a polyacrylamide gel.
Arrows on the right side of the panel indicate the predicted mRNA bands for STAT and SOCS (a). The density of each band was analyzed using the
Diversity Databaset (PDI Inc., NewYork). Relative values for SOCS3/CIS3 (b), SOCS1/JAB (c), SOCS2/CIS2 (d), and CIS1 mRNA (e) were estimated
using GAPDH as an internal reference, and normalized against the respective relative value at 0 h poststimulation. Each bar represents the mean of relative
values obtained from three independent experiments using keratinocytes derived from three independent donors. The error bars indicate standard
deviations.
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Keratinocyte-speci¢c negative feedback pro¢le of SOCS1/
JAB SOCS1/JAB is a potent negative regulator of IL-6-
induced STAT3 phosphorylation in leukemia cells, but not in
keratinocytes. This keratinocyte-speci¢c characteristic of SOCS1/
JAB was analyzed. To con¢rm whether SOCS1/JAB inhibited
the IL-6-induced signaling pathway, we examined the e¡ect
of AxCALNLJAB on the SOCS3/CIS3 mRNA expres-
sion induced by IFN-g and IL-6. AxCALNLJAB inhibited
IFN-g-dependent SOCS3/CIS3 mRNA induction, as did
AxCASTAT1F, a dominant negative STAT1 (Fig 8a). On the
other hand, AxCASTAT3F, a dominant negative STAT3,
inhibited IL-6-dependent SOCS3/CIS3 mRNA induction,
whereas AxCALNLJAB did not (Fig 8c). Time-course studies of
AxCALNLJAB-transfected keratinocytes con¢rmed that IFN-g-
dependent SOCS3/CIS3 induction was inhibited by SOCS1/JAB,
but IL-6-dependent induction was not (Fig 8b,d). These data
verify that SOCS1/JAB does not inhibit IL-6-induced STAT3
activation in keratinocytes.
DISCUSSION
Binding of IFN-g to its receptor activates STAT1. Phosphorylated
STAT1 forms a homodimer and transduces the IFN-g signal in
keratinocytes, inducing the expression of the intercellular adhe-
sion molecule-1, and enhancing the allergic reaction (Jiang et al,
1994; Naik et al, 1997). STAT2 forms a heterodimer with STAT1
that associates with p48 to transduce the IFN-a/b signal (Schind-
ler and Darnell, 1995). Although the speci¢c function of STAT2
in keratinocyte biology is not well understood, keratinocytes
produce IFN-b (Fujisawa et al, 1997), and STAT2 may transduce
the IFN-a/b signal in keratinocytes. Whereas keratinocytes de-
rived from STAT3-de¢cient mice have impaired migration (Sano
et al, 1999), speci¢c functions for STAT4, STAT5a, and STAT5b in
keratinocytes have not been reported. STAT6 may transduce IL-4
and IL-13 signals, and modulate the expression of CD60w, a T
cell costimulatory factor (Huang et al, 2001). Thus, in keratino-
cytes, STAT signal modulation may in£uence the response to
Figure 2. Induction of SOCS/CIS mRNA by IL-6 in keratinocytes. IL-6 (10 ng per ml) was added to keratinocytes in culture medium, and total
RNAwas extracted at 0, 1, 3, 6, 12, 24, 36, and 48 h after stimulation. A gel image of a ribonuclease protection assay is shown (a), and relative values for
SOCS3/CIS3 (b), SOCS1/JAB (c), SOCS2/CIS2 (d), and CIS1 mRNA (e) were estimated as described in the legend of Fig 1.
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in£ammatory signals and mobility. The SOCS/CIS family
is induced by cytokine stimulation and acts as a negative regula-
tor of the cytokine signal, which leads to the suppression of
STAT activation. Therefore, SOCS/CIS family induction may be
one of the key regulatory mechanisms in the skin in£ammatory
reaction.
Strong IFN-g induction of STAT1 and STAT2 may indicate the
importance of these molecules in the IFN-g signaling pathway
and IFN-g e¡ect on keratinocytes. Along with the induction of
STAT1 and STAT2 mRNA, SOCS1/JAB and SOCS3/CIS3
mRNA were expressed in human keratinocytes (Fig 1a). After
IFN-g stimulation, SOCS3/CIS3 mRNA expression preceded
that of SOCS1/JAB; SOCS3/CIS3 mRNA was detected 1 h
after exposure to IFN-g, and SOCS1/JAB was detected after 3 h
(Fig 1a). Thus, IFN-g-induced SOCS3/CIS3 mRNA expression
preceded SOCS1/JAB mRNA induction. IFN-g-induced STAT1
phosphorylation was strongly inhibited by SOCS1/JAB and
weakly inhibited by SOCS3/CIS3 (Fig 5a). These results indicate
that the SOCS3/CIS3 induced earlier may have partially inhib-
ited IFN-g-dependent STAT1 phosphorylation, and SOCS1/JAB
induction following SOCS3/CIS3 had a potent inhibitory e¡ect
on STAT1 activation, and also inhibited the anti-proliferative ef-
fect of IFN-g. These phenomena represent the dual negative reg-
ulatory system of the SOCS family following IFN-g stimulation
in keratinocytes: SOCS3/CIS3 ¢rst inhibits or modulates weak
IFN-g stimulation. If keratinocytes are exposed to IFN-g for a
long period, SOCS1/JAB is induced and blocks the IFN-g signal-
ing pathway intensively. Thus, IFN-g stimulation is counteracted
by SOCS3/CIS3 at an early phase and by SOCS1/JAB at a late
phase. Therefore, sequential negative regulation by SOCS3/CIS3
and SOCS1/JAB may play a central part in the keratinocyte
IFN-g/STAT1 signaling pathway.
Figure 3. Induction of SOCS/CIS mRNA by IL-4 in keratinocytes. IL-4 (10 ng per ml) was added to keratinocytes in culture medium, and total
RNAwas extracted at 0, 1, 3, 6, 12, 24, 36, and 48 h after stimulation. A gel image of a ribonuclease protection assay is shown (a), and relative values for
SOCS3/CIS3 (b), SOCS1/JAB (c), SOCS2/CIS2 (d), and CIS1 mRNA (e) were estimated as described in the legend of Fig 1.
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SOCS1/JAB, CIS1, and SOCS3/CIS3 were inducible in pri-
mary keratinocytes (Fig 9). Interestingly, the SOCS family has
di¡erent functions in keratinocytes and other cell types. In mye-
loid leukemia M1 cells, IL-6 induces SOCS1/JAB, and SOCS1/
JAB inhibits IL-6-induced STAT3 activation (Endo et al, 1997;
Naka et al, 1997; Starr et al, 1997). IL-6 strongly enhanced the ex-
pression of SOCS3/CIS3 mRNA and AxCACIS3 completely in-
hibited IL-6-induced STAT3 phosphorylation in keratinocytes
(Figs 2a and 6a,c); however, SOCS1/JAB mRNA was not in-
duced by IL-6 stimulation and AxCALNLJAB did not a¡ect IL-
6-dependent STAT3 phosphorylation (Figs 2a and 6a,b).
SOCS1/JAB also failed to inhibit IL-6-dependent SOCS3/CIS3
mRNA induction, which was interrupted by the dominant ne-
gative STAT3 adenovirus vector (Fig 8c,d). These results suggest
that SOCS3/CIS3 is a major negative regulator in the IL-6-in-
duced STAT3 signaling pathway in keratinocytes. These data
may also suggest that there is a speci¢c mechanism of IL-6-in-
duced STAT3 activation and a speci¢c role for SOCS3/CIS3 in
the IL-6 signaling pathway in primary keratinocytes. Recently,
Nicholson et al (2000) reported a di¡erential inhibitory mechan-
ism between SOCS1/JAB and SOCS3/CIS3 in the IL-6 receptor,
gp130. They reported that SOCS1/JAB binds to JAK1, but does
not bind to gp130. In contrast to SOCS1/JAB, SOCS3/CIS3 binds
to gp130 directly, but this does not inhibit JAK1 phosphorylation.
The fact that SOCS1/JAB does not inhibit the IL-6/STAT3 path-
way suggests that STAT3 phosphorylation does not depend on
the JAK1 pathway in primary keratinocytes. EGF is reported to
activate STAT3 without JAK1 activation (David et al, 1996), and
IL-6 and EGF activate STAT3 not only via JAK1, but also via src
(Lund et al, 1999; Zhang et al, 2000). In fact, the src inhibitor PP2
Figure 4. Induction of SOCS/CIS mRNA by EGF in keratinocytes. EGF (10 ng per ml) was added to keratinocytes in culture medium, and total
RNAwas extracted at 0, 1, 3, 6, 12, 24, 36, and 48 h after stimulation. A gel image of a ribonuclease protection assay is shown (a), and relative values for
SOCS3/CIS3 (b), SOCS1/JAB (c), SOCS2/CIS2 (d), and CIS1 mRNA (e) were estimated as described in the legend of Fig 1.
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inhibited IL-6-dependent STAT3 phosphorylation in primary
keratinocytes (data not shown). Hence, the pathway from gp130
to src could be either a main or supplementary pathway for kera-
tinocyte IL-6-dependent STAT3 signaling. This might explain
why SOCS1/JAB does not inhibit IL-6-induced STAT3 activa-
tion in these cells.
IL-4 induced SOCS1/JAB and CIS1 mRNA, and AxCALNL-
JAB inhibited IL-4-dependent STAT6 phosphorylation (Figs 3a
and 7a,b). These data reveal the e¡ect of SOCS1/JAB in the nor-
mal keratinocyte IL-4 signaling pathway. Although a previous re-
port showed that SOCS3/CSI3 inhibits IL-4-dependent STAT6
activation (Haque et al, 2000), SOCS3/CIS3 had no e¡ect on IL-
4-induced STAT6 phosphorylation in human keratinocytes
(Fig 7a). Hence, the SOCS1/JAB protein is a major negative reg-
ulator of IL-4-induced STAT6 activation. SOCS1/JAB was
Figure 5. Inhibition of IFN-c-induced STAT1 activation by SOCS/
CIS. Twenty-four hours after transfection with adenovirus vectors, IFN-g
(10 IU per ml) was added to keratinocytes in culture medium; proteins
were extracted 15 min after stimulation (a) and at the indicated time (b,c).
Western blot analyses were performed with anti-phosphoSTAT1 and anti-
STAT1 antibodies.
Figure 6. Inhibition of IL-6-induced STAT3 activation by SOCS/
CIS. Twenty-four hours after transfection with adenovirus vectors, IL-6
(10 ng per ml) was added to keratinocytes in culture medium; proteins
were extracted 15 min after stimulation (a) and at the indicated time (b,c).
Western blot analyses were performed with anti-phosphoSTAT3 and anti-
STAT3 antibodies.
Figure 7. Inhibition of IL-4-induced STAT6 activation by SOCS/
CIS. Twenty-four hours after transfection with adenovirus vectors, IL-4
(10 ng per ml) was added to keratinocytes in culture medium; proteins
were extracted 15 min after stimulation (a) and at the indicated time (b,c).
Western blot analyses were performed with anti-phosphoSTAT6 and anti-
STAT6 antibodies.
Figure 8. Inhibition of SOCS3/CIS3 mRNA induction by SOCS/
CIS. Twenty-four hours after transfection with adenovirus vectors, IFN-g
(10 IU per ml) (a,b) or IL-6 (10 ng per ml) (c,d) was added to keratinocytes
in culture medium; total RNAwas extracted 1 h after stimulation (a,c) and
at the indicated time (b,d). The expression of SOCS3/CIS3 mRNA and
GAPDH mRNA is indicated.
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induced by IFN-g and IL-4 stimulation, and overexpressed
SOCS1/JAB inhibited the IFN-g/STAT1 and IL-4/STAT6 signals
(Fig 9). Thus, SOCS1/JAB acts as a negative feedback mechanism
of IFN-g and IL-4 stimulation in keratinocytes. IFN-g is one of
the major Th1 cytokines, and IL-4 is aTh2 cytokine. SOCS1/JAB
may contribute to homeostasis of the Th1 and Th2 signals in ker-
atinocytes. Huang et al (2001) reported that pretreatment with
IFN-g inhibits keratinocyte IL-4-dependent CD60w expression.
Combined, our data indicate that SOCS1/JAB regulates the cross-
talk between IFN-g and IL-4. SOCS3/CIS3 was induced by
IFN-g and IL-6 stimulation (Figs 1 and 2), and completely inhib-
ited IL-6/STAT3 signals (Fig 6a,c). This suggests that pretreat-
ment with IFN-g blocked the IL-6 signal pathway when IL-6
was added after IFN-g (Fig 9); IL-6 appeared to suppress the
IFN-g signal. Thus, the SOCS family may regulate the homeos-
tasis of cytokine signals in primary keratinocytes.
Psoriasis is characterized by hyperproliferation and incomplete
terminal di¡erentiation of the epidermis. Previous studies sug-
gested that calcium ions regulate keratinocyte growth and di¡er-
entiation, and that a calcium gradient exists in the epidermis
(Menon et al, 1985). Loss of this gradient and altered calcium
metabolism have been observed in psoriatic keratinocytes (Menon
and Elias, 1991; Karvonen et al, 2000). Altered calcium signaling
and a persistent in£ammatory reaction might be involved in the
formation of the characteristic psoriatic epidermis. IFN-g is
secreted from Th1 lymphocyte, and is a possible psoriasis patho-
gen (Schlaak et al, 1994). IFN-g activates STAT1 and induces the
expression of molecules that recruit and activate T cells and other
leukocytes in the skin (Barker et al, 1990). SOCS1/JAB-de¢cient
mice manifest a thickened epidermis with lymphocyte in¢ltra-
tion into the dermis, much like psoriasis (Metcalf, 1999). In these
mice, the IFN-g signal is not regulated by a negative feedback
mechanism involving SOCS1/JAB, and the in£ammatory reac-
tion persists. It was reported that administering IFN-g under
normal human epidermis induces psoriasis phenotypes, but these
psoriatic reactions resolve quickly (Barker et al, 1993; Fransson
et al, 1996). SOCS1/JAB-de¢cient mice cannot terminate the
IFN-g-induced in£ammatory reaction, which may result in a
longitudinal psoriasis phenotype. Th2-derived cytokine IL-4 is
abundantly expressed in atopic dermatitis (Del Prete, 1992; Furue,
1994; Ricci, 1994). The balance between Th1 and Th2 cells a¡ects
both keratinocyte growth and the expression of chemoattractants
by keratinocytes (Fransson et al, 1996; Vestergaard et al, 2000).
SOCS1/JAB acts as a negative feedback mechanism of IFN-g-
and IL-4-induced signal transduction in keratinocytes (Fig 9).
Thus, SOCS are essential for the regulation of in£ammatory re-
actions, and may act to terminate persistent in£ammatory diseases
of the skin. Together, the SOCS family is the key regulator of
in£ammatory reactions, and SOCS family dysfunction is in-
volved in the pathophysiology of many in£ammatory skin dis-
eases, such as psoriasis and atopic dermatitis.
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